INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. BUYMTDRMatador Resources CoNov 5 – Nov 56 insiders$507K
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K

Form 4 transactions

18,684 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
1
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$197K
340 sh
Apr 20, 2026Apr 21, 2026
Page 270 of 468
← PrevNext →
traded Apr 20, 2026
+1d
SEC Form 4

Evidence

1
CL
Collins Helen LouiseCHIEF MEDICAL OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$6,413
140 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

0
WC
Wren ChrisVP of Operations
PLNHPlanet 13 Holdings Inc.
Open-market sale · 10b5-1 plan
SELL$4,521
30.0K sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

0
WC
Wren ChrisVP of Operations
PLNHPlanet 13 Holdings Inc.
Open-market sale · 10b5-1 plan
SELL$384
2,500 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

50
BS
Baugher Joshua ScottChief Financial Officer
AGXARGAN INC
Open-market sale
SELL$363K
600 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

44
Bhatt BaijuDirector
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$2.42M
28.0K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

41
Bhatt BaijuDirector
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$875K
10.0K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

41
RN
Rogers Mark NEVP & General Counsel
AMKRAMKOR TECHNOLOGY, INC.
Open-market sale
SELL$297K
5,000 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

38
KS
Karmiri StefaniaCorporate Secretary
ESEAEUROSEAS LTD.
Open-market sale
SELL$18K
250 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

38
Bhatt BaijuDirector
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$133K
1,500 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

37
Bhatt BaijuDirector
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$976K
11.4K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

36
LM
Lichtman MosheDirector
VLNValens Semiconductor Ltd.
Open-market sale
SELL$5,513
3,750 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

35
GM
Gline MatthewDirector, CEO
ROIVRoivant Sciences Ltd.
Open-market sale
SELL$8.45M
289.8K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

35
SS
Subotovsky SantiagoDirector
ZMZoom Communications, Inc.
Open-market sale · 10b5-1 plan
SELL$97K
1,106 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

34
AL
Antonoff LaurenDirector, Chief Executive Officer
LIFLife360, Inc.
Open-market sale
SELL$123K
2,716 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

34
SA
Saha AnuragCHIEF ACCOUNTING OFFICER
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$1.35M
3,157 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

33
NC
Nakamura Eileen CheighDirector
GAB.RTGABELLI EQUITY TRUST INC
Open-market sale
SELL$742
9,640 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

33
Bhatt BaijuDirector
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$541K
6,400 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

32
SS
Subotovsky SantiagoDirector
ZMZoom Communications, Inc.
Open-market sale · 10b5-1 plan
SELL$9,810
111 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

32
SS
Subotovsky SantiagoDirector
ZMZoom Communications, Inc.
Open-market sale · 10b5-1 plan
SELL$5,365
60 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

32
YT
Yaacobi TalDirector
VLNValens Semiconductor Ltd.
Open-market sale
SELL$5,513
3,750 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

31
SS
Subotovsky SantiagoDirector
ZMZoom Communications, Inc.
Open-market sale · 10b5-1 plan
SELL$96K
1,111 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

31
PB
Piekos BrianChief Financial Officer
KALVKalVista Pharmaceuticals, Inc.
Open-market sale
SELL$38K
1,862 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

30
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Open-market sale
SELL$54K
2,686 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

29
SC
Swenson Christopher C.Chief Legal Officer
NRDYNerdy Inc.
Open-market sale
SELL$65K
69.8K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

28
UJ
Ullal JayshreeDirector, CEO and Chairperson
ANETArista Networks, Inc.
Open-market sale · 10b5-1 plan
SELL$36.49M
229.2K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

27
CP
Coen Steven P.See remarks
DNAGinkgo Bioworks Holdings, Inc.
Open-market sale
SELL$2,576
324 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

27
SN
Sweeny NicoleChief Commercial Officer
KALVKalVista Pharmaceuticals, Inc.
Open-market sale
SELL$38K
1,862 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

26
PA
Paszterko John AndrewChief Operating Officer
NRDYNerdy Inc.
Open-market sale
SELL$30K
31.8K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

26
GF
Grossman Eric FChief Legal/Admin Officer
MSMORGAN STANLEY
Open-market sale
SELL$1.06M
5,559 sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

26
GF
Grossman Eric FChief Legal/Admin Officer
MSMORGAN STANLEY
Open-market sale
SELL$1.06M
5,559 sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

25
UJ
Ullal JayshreeDirector, CEO and Chairperson
ANETArista Networks, Inc.
Open-market sale · 10b5-1 plan
SELL$7.30M
45.8K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

25
UJ
Ullal JayshreeDirector, CEO and Chairperson
ANETArista Networks, Inc.
Open-market sale · 10b5-1 plan
SELL$7.30M
45.8K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

25
UJ
Ullal JayshreeDirector, CEO and Chairperson
ANETArista Networks, Inc.
Open-market sale · 10b5-1 plan
SELL$3.34M
20.8K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

23
TR
Timmerman Douglas R.President, DFS
ALLYAlly Financial Inc.
Open-market sale · 10b5-1 plan
SELL$1.79M
39.7K sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

23
SS
Subotovsky SantiagoDirector
ZMZoom Communications, Inc.
Open-market sale · 10b5-1 plan
SELL$84K
958 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

23
SS
Subotovsky SantiagoDirector
ZMZoom Communications, Inc.
Open-market sale · 10b5-1 plan
SELL$108K
1,250 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

22
UJ
Ullal JayshreeDirector, CEO and Chairperson
ANETArista Networks, Inc.
Open-market sale · 10b5-1 plan
SELL$669K
4,166 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

22
UJ
Ullal JayshreeDirector, CEO and Chairperson
ANETArista Networks, Inc.
Open-market sale · 10b5-1 plan
SELL$669K
4,166 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

22
MD
Munagala DinakarDirector, Chief Executive Officer
BZAIBlaize Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$127K
50.0K sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence